Regeneron Pharmaceuticals
REGN
REGN
622 hedge funds and large institutions have $25B invested in Regeneron Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 69 funds opening new positions, 239 increasing their positions, 211 reducing their positions, and 59 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
622
Holders Change
+4
Holders Change %
+0.65%
% of All Funds
14.26%
Holding in Top 10
12
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.28%
New
69
Increased
239
Reduced
211
Closed
59
Calls
$566M
Puts
$893M
Net Calls
-$328M
Net Calls Change
-$60.8M
Top Buyers
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
$1.48B |
| 2 |
O
OrbiMed
New York
|
$129M |
| 3 |
JIM
Jupiter Investment Management
London,
United Kingdom
|
$31.7M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$273M |
| 5 |
D.E. Shaw & Co
New York
|
$112M |
